Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from Vivos Therapeutics ( (VVOS) ) is now available.
Effective February 4, 2026, Vivos Therapeutics appointed Gregg C. E. Johnson as an independent director to its board of directors, also assigning him to the compensation committee and compensating him in line with its standard non-employee director cash and equity policies. Johnson, who previously served as the company’s secretary and director, brings a Juris Doctorate and extensive experience in law, corporate compliance, capital markets, and leadership roles at various high-growth and public-company-focused enterprises in Canada and the United States, which the company believes strengthens its governance capabilities and supports its growth and regulatory objectives.
The most recent analyst rating on (VVOS) stock is a Hold with a $1.50 price target. To see the full list of analyst forecasts on Vivos Therapeutics stock, see the VVOS Stock Forecast page.
Spark’s Take on VVOS Stock
According to Spark, TipRanks’ AI Analyst, VVOS is a Neutral.
The score is held down primarily by weak financial performance (persistent losses, worsening cash burn, and a more pressured balance sheet) and bearish technical signals (price below key moving averages with negative MACD). Offsetting factors include strong recent revenue growth and a strategic pivot highlighted on the earnings call, but ongoing cost escalation and the need for bridge/equity financing keep risk elevated, while valuation offers limited support due to negative earnings and no dividend.
To see Spark’s full report on VVOS stock, click here.
More about Vivos Therapeutics
Vivos Therapeutics, Inc. operates in the healthcare sector, focusing on therapeutic solutions, and is governed by a board of directors that follows standard U.S. public company practices for director compensation and corporate governance, including cash fees and equity incentive plans for non-employee directors.
Average Trading Volume: 130,523
Technical Sentiment Signal: Sell
Current Market Cap: $14.16M
See more insights into VVOS stock on TipRanks’ Stock Analysis page.